BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26687264)

  • 21. Primary diffuse large B-Cell lymphoma of the prostate presenting with urinary retention and dyschezia for which rituximab-combined CHOP therapy was effective-a case presentation.
    Manabe M; Hayashi Y; Yoshii Y; Mukai S; Sakamoto E; Kanashima H; Nakao T; Hayama T; Fukushima H; Inoue T; Yamane T; Teshima H
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1733-5. PubMed ID: 23152030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-body (18)F-FDG PET/CT in primary non-Hodgkin's lymphoma of the thyroid associated with Hashimoto's thyroiditis and bilateral kidney infiltration.
    Roldán-Valadez E; Ortega-López N; Cervera-Ceballos E; Valdivieso-Cárdenas G; Vega-González I; Granados-García M
    Rev Esp Med Nucl; 2008; 27(1):34-9. PubMed ID: 18208780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary ovarian lymphoma--a rare entity.
    Afshan A; Sadaf N
    J Pak Med Assoc; 2013 Apr; 63(4):519-20. PubMed ID: 23905454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolated central nervous system relapse in a patient with systemic diffuse large B-cell lymphoma: Diagnostic and treatment challenges.
    Das P; Dubashi B; Joseph D; Jain A
    Indian J Cancer; 2014; 51(4):468-9. PubMed ID: 26842164
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravascular Large B-Cell Lymphoma of the Gallbladder.
    Çetin B; Akyürek N; Metin Y; Karaca F; Bilgetekin İ; Özet A
    Turk J Haematol; 2018 May; 35(2):145-146. PubMed ID: 29391332
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.
    Stefancikova L; Moulis M; Fabian P; Vasova I; Zedek F; Ravcukova B; Muzik J; Kuglik P; Vranova V; Falkova I; Hrabalkova R; Smardova J
    Int J Oncol; 2011 Dec; 39(6):1413-20. PubMed ID: 21874232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravascular large B-cell lymphoma--a diagnostic dilemma.
    Ramkumar B; Hutchison R; Khadim H; Gajra A
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):e18-21. PubMed ID: 24060286
    [No Abstract]   [Full Text] [Related]  

  • 28. Asymptomatic gastrosplenic fistula in a patient with marginal zonal lymphoma transformed to diffuse large B cell lymphoma--a case report and review of literature.
    Senapati J; Devasia AJ; Sudhakar S; Viswabandya A
    Ann Hematol; 2014 Sep; 93(9):1599-602. PubMed ID: 24362455
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens.
    Goto N; Tsurumi H; Kasahara S; Kanemura N; Hara T; Yasuda I; Shimizu M; Murakami N; Sawada M; Yamada T; Takemura M; Seishima M; Kito Y; Takami T; Moriwaki H
    Eur J Haematol; 2011 Sep; 87(3):217-27. PubMed ID: 21575062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A longitudinal study of non-medical determinants of adherence to R-CHOP therapy for diffuse large B-cell lymphoma: implication for survival.
    Borel C; Lamy S; Compaci G; Récher C; Jeanneau P; Nogaro JC; Bauvin E; Despas F; Delpierre C; Laurent G
    BMC Cancer; 2015 Apr; 15():288. PubMed ID: 25884669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.
    Moore S; Peggs K; Thomson K; Lowry L; Ljubic A; Goldstone AH; Linch DC; Ardeshna KM
    Br J Haematol; 2012 Jan; 156(1):142-3. PubMed ID: 21848889
    [No Abstract]   [Full Text] [Related]  

  • 32. Histological improvement in salivary gland along with effector memory Th17-1 cell reduction in a primary Sjogren's syndrome patient with dermatomyositis and diffuse large B-cell lymphoma by R-CHOP therapy.
    Koga T; Mizokami A; Nakashima M; Shimizu T; Nakashima Y; Nakamura H; Chiwata M; Daisuke N; Kawakami A
    Clin Immunol; 2016 Apr; 165():35-7. PubMed ID: 26960952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of primary hepato-biliary malignant lymphoma effectively treated with R-CHOP chemotherapy].
    Hiramoto K; Kuroki M; Shoji H; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H; Kimura J; Matsuda M
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1345-8. PubMed ID: 20647724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonpegylated Liposomal Doxorubicin as a Component of R-CHOP Is an Effective and Safe Alternative to Conventional Doxorubicin in the Treatment of Patients With Diffuse Large B-Cell Lymphoma and Preexisting Cardiac Diseases.
    Rohlfing S; Aurich M; Schöning T; Ho AD; Witzens-Harig M
    Clin Lymphoma Myeloma Leuk; 2015 Aug; 15(8):458-63. PubMed ID: 25899891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of therapeutic outcomes between surgical resection followed by R-CHOP and R-CHOP alone for localized primary intestinal diffuse large B-cell lymphoma.
    Lee HS; Park LC; Lee EM; Shin SH; Ye BJ; Oh SY; Song MK; Lee SM; Lee WS; Kang BW; Chang MH; Cho SG; Yahng SA; Yoon SS; Kwon JH; Kim YS
    Am J Clin Oncol; 2014 Apr; 37(2):182-7. PubMed ID: 23211226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: case report.
    Niino D; Ohsaki K; Arakawa F; Watanabe J; Kimura Y; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Sugita Y; Ohshima K; Okamura T
    Pathol Int; 2011 Jun; 61(6):363-8. PubMed ID: 21615612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Yoo C; Lee DH; Kim JE; Jo J; Yoon DH; Sohn BS; Kim SW; Lee JS; Suh C
    Ann Hematol; 2011 Jul; 90(7):797-802. PubMed ID: 21181163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. R-CHOP versus R-COMP: are they really equally effective?
    Mian M; Wasle I; Gamerith G; Mondello P; Melchardt T; Jäger T; Linkesch W; Fiegl M
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):648-52. PubMed ID: 24929649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment.
    Hitz F; Connors JM; Gascoyne RD; Hoskins P; Moccia A; Savage KJ; Sehn LH; Shenkier T; Villa D; Klasa R
    Ann Hematol; 2015 Nov; 94(11):1839-43. PubMed ID: 26246466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
    N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.